To investigate whether the distinct patterns of Ro52 detection by SLE sera and commercial antibodies in SLE leukocytes is explained by targeting unique Ro52 isoforms, we focused on splicing variants upregulated in circulating SLE cells. The gene discussed is TRIM21; the disease is systemic lupus erythematosus.